Fahnoe U, Pedersen MS, Solund C, Ernst A, et al. Global evolutionary analysis of chronic hepatitis C patients revealed significant
effect of baseline viral resistance, including novel non-target sites, for
DAA-based treatment and retreatment outcome. J Viral Hepat 2020 Oct 31. doi: 10.1111/jvh.13430.
PMID: 33131178